This gilteritinib stuff is a FLT3 inhibitor, which is a big deal for treating Acute Myeloid Leukemia, AML, especially when it comes back or doesn’t respond to treatment. It’s mainly for AML with FLT3 mutations. So it works by shutting down this FLT3 kinase thing, which helps to slow down those leukemia cells from multiplying.
It comes in these 40 mg tablets that are all nicely coated. You’re supposed to take 120 mg of this once every day. You get these in bottles, each with 90 tablets.
Patients need to know that this gilteritinib is only for certain FLT3 mutations and not for all AMLs. And, hey, you gotta keep a close eye on this stuff, okay? It’s best to have a healthcare professional handle it.
Reviews
There are no reviews yet.